GlassScriptPhysician profile
Gilbert A Fishbein
NPI 1528058666
$2,952.46
in general payments reported to CMS, 2019-2025
20 companies · $1,515 in 2025
The $1,515 reported for 2025 was more than what 96% of Anesthesiology providers received nationally (typical 2025 total: $58.09).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $22.41 · 2022: $12.95 · 2023: $414 · 2024: $989 · 2025: $1,515.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,917.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,917.10 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Takeda Pharmaceuticals U.S.A., INC. | $787.58 | 2022-2025 | Entyvio, Eohilia, Gattex |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $400.24 | 2020-2025 | Xifaxan, Trulance, Plenvu |
| Qol Medical, LLC | $286.90 | 2023-2025 | Sucraid, Sucraid |
| Janssen Biotech, INC. | $286.62 | 2024-2025 | Stelara, Tremfya |
| Regeneron Healthcare Solutions, INC. | $246.01 | 2023-2025 | Dupixent |
| Ardelyx, INC. | $205.09 | 2023-2025 | Ibsrela |
| Madrigal Pharmaceuticals | $106.24 | 2025 | Rezdiffra |
| Ipsen Biopharmaceuticals, INC | $93.82 | 2025 | Iqirvo |
| Intercept Pharmaceuticals, INC. | $92.08 | 2023-2025 | Ocaliva |
| Organon LLC | $81.95 | 2024-2025 | Hadlima, Renflexis |
| Fresenius Kabi USA, LLC | $72.14 | 2023-2024 | Idacio |
| Phathom Pharmaceuticals, INC. | $65.93 | 2025 | Voquezna |
| Neuraxis, INC. | $54.32 | 2025 | |
| Braintree Laboratories, INC. | $42.78 | 2023-2025 | Sutab, Suflave |
| Lilly USA, LLC | $40.06 | 2024-2025 | Omvoh, Zepbound |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $22.99 | 2025 | The Cologuard Plus Collection Kit |
| Abbvie INC. | $20.68 | 2025 | |
| Sandoz INC. | $16.48 | 2023 | Hyrimoz |
| Laborie Medical Technologies Corp. | $16.04 | 2024 | Alphaone |
| Digestive Care, INC. | $14.51 | 2024 | Pertzye |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gilbert Fishbein listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.